A longitudinal program for biomarker development in Parkinson's disease: A feasibility study-Reference-Cited by-同舟云学术

A longitudinal program for biomarker development in Parkinson's disease: A feasibility study

Published:2009-10-30 Issue:14 Volume:24 Page:2081-2090
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Ravina Bernard,Tanner Caroline,DiEuliis Diane,Eberly Shirley,Flagg Emily,Galpern Wendy R.,Fahn Stanley,Goetz Christopher G.,Grate Stephen,Kurlan Roger,Lang Anthony E.,Marek Kenneth,Kieburtz Karl,Oakes David,Elliott Robin,Shoulson Ira,

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference39 articles.

1. Biomarkers in Parkinson's disease;Dorsey;Expert Rev Neurother,2006

2. Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a National Institutes of Health Workshop;De Gruttola;Control Clin Trials,2001

3. Translational and clinical science-time for a new vision;Zerhouni;N Engl J Med,2005

4. Parkinson Study Group. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease;Neurology,2007

5. Consensus statement on the diagnosis of multiple system atrophy;Gilman;J Neurol Sci,1999

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explainable AI approach for early detection of Parkinson’s disease using PPMI Online data;Neural Computing and Applications;2024-08-03

2. Machine learning within the Parkinson’s progression markers initiative: Review of the current state of affairs;Frontiers in Aging Neuroscience;2023-02-13

3. Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change;Movement Disorders;2021-07-30

4. Distinct progression patterns across Parkinson disease clinical subtypes;Annals of Clinical and Translational Neurology;2021-07-26

5. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease;Nature Genetics;2021-05-06